-

Wolters Kluwer and Smile Train increase access to critical medical research

The organizations will bring clinical publications to care teams in need of additional resources, helping advance Smile Train’s vision globally

WALTHAM, Mass.--(BUSINESS WIRE)--Access to medical information in low-and-middle-income countries continues to hinder global health equity. To help meet this universal need, Wolters Kluwer Health and Smile Train, the world’s largest cleft-focused organization, are collaborating to bring full online access to select medical journals for Smile Train partners and affiliates globally. The vital resources will be available to Smile Train’s network of local clinicians through Wolters Kluwer’s Ovid® research platform.

Removing barriers to clinical information

With limited budgets, access to medical journals can be difficult for healthcare workers in low resource settings. Nearly 71% of Smile Train partners report that access to journal articles is a challenge they face when developing research. Additionally, 58% of partners note that access to journal information is a high priority for them in the development of cleft research. Through this initiative, care teams that may not have previously had access to key medical titles, like the New England Journal of Medicine, Plastic and Reconstructive Surgery, and Journal of Craniofacial Surgery, now have instant access to help support healthcare programs around the world.

“Medical research continues to expand and grow, with more global contributions happening than ever before. Wolters Kluwer and Smile Train are both dedicated to increasing equity in access to medical literature and publications throughout the world,” said Rafael Sidi, Senior Vice President & General Manager of Health Research, Wolters Kluwer Health.

Changing the face of global health

Smile Train is a nonprofit organization that has helped children in more than 70 countries, empowering local medical professionals with training, funding, and resources to provide free cleft surgery and comprehensive cleft care to children globally. The organization advances a sustainable and scalable global health model for cleft treatment, drastically improving children’s lives, including their ability to eat, breathe, speak, and ultimately thrive.

“As Smile Train embarks on its 25th year of supporting cleft care around the world, this collaboration is another transformative milestone in how we are able to impact patient outcomes,” said Susannah Schaefer, President and CEO of Smile Train. “Bringing timely, trusted medical information to all of our local health professionals allows them to help ensure that children with clefts have everything they need to thrive. We are thrilled to add these resources, which reinforce our commitment of providing safe, high-quality and free comprehensive cleft care to children globally.”

Connecting to the world’s most trusted clinical research platform

To help drive global health equity, consistent and trusted evidence must be available at the point of care, point of discovery, point of reference, and point of learning. Smile Train’s collaboration with Wolters Kluwer directly addresses the challenges surrounding access to clinical research and provides their partners with up-to-date research on best practices in their field. Access to these journals and the Ovid research platform will benefit Smile Train partners, affiliates, and staff in their work as well as in expanding research and clinical knowledge.

Ovid delivers thousands of full-text journal articles, eBooks, database resources, and workflow tools in a single integrated solution – making it the leading choice globally among clinicians, researchers, educators and students in the medical, scientific and academic fields.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software, and services for professionals in healthcare, tax and accounting, financial and corporate compliance, legal and regulatory, and corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2022 annual revenues of €5.5 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 20,900 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, and YouTube.

Contacts

Media:
Josh DeStefano
Manager, External Communications
Wolters Kluwer Health
+1 (917) 408-5125
joshua.destefano@wolterskluwer.com

Nicole Bell
Vice President, Public Relations
Smile Train
(646) 829-0996
nbell@smiletrain.org

Wolters Kluwer Health

AEX:WKL

Release Versions

Contacts

Media:
Josh DeStefano
Manager, External Communications
Wolters Kluwer Health
+1 (917) 408-5125
joshua.destefano@wolterskluwer.com

Nicole Bell
Vice President, Public Relations
Smile Train
(646) 829-0996
nbell@smiletrain.org

Social Media Profiles
More News From Wolters Kluwer Health

Wolters Kluwer Expands Reach With New Virtual Simulation Nursing Resources

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer launches 2 new virtual simulation nursing resources: a definitive curriculum guide & a webinar on simulation for nurse practitioners....

Wolters Kluwer announces institutional availability of NEJM AI on Ovid

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health and NEJM Group, publishers of the New England Journal of Medicine (NEJM), announced today that the new NEJM AI journal is now available on Wolters Kluwer’s Ovid® medical research platform. NEJM AI is a peer-reviewed monthly journal dedicated to exploring and integrating artificial intelligence (AI) in clinical medicine. Hospitals, government agencies, corporations, health systems and research institutions are able to access the journal orga...

Leading children’s hospitals turn to innovative Wolters Kluwer solution to help improve clinical outcomes

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health today announced that three of the top children’s hospitals in the US have adopted Ovid® Synthesis to meet their clinical research needs. At a time when medical research is moving at a break-neck pace, it is more important than ever for hospitals and health systems to rely on trustworthy, evidence-based practice (EBP) workflow applications—especially when children’s care is on the line. “These highly regarded healthcare organizations have bu...
Back to Newsroom